Protalix Biotherapeutics inc (PLX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PLX Annual Balance Sheets →
The data below summarizes Protalix Biotherapeutics inc's balance sheet position from Jun 30 2025 to Jun 30 2026, enabling a period-by-period comparison of financial strength.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent27.42
Restricted Cash and Cash Equivalents, Current0.72
Cash & Short-term Investments27.00
Accounts receivable16.50
Inventories32.29
Other Current Assets15.29
Total Current Assets92.22
Equipment/Property/Plant Net5.47
Defined Benefit Plan, Assets for Plan Benefits, Noncurrent DE0.00
Other Assets, Noncurrent12.65
Short Term Bank Deposits10.08
Operating Lease Right Of Use Asset7.79
Total Assets110.34
Liabilities
Accounts Payable, Trade, Current6.51
Accrued Liabilities, Current9.96
Other Liabilities, Current10.71
Taxes Payable4.22
Total Current Liabilities31.39
Total Long-term Debt0.00
Pension and Other Postretirement and Postemployment Benefit Plans, Liabilities, Noncurrent0.00
Other liabilities, Noncurrent7.54
Operating Lease Liability Current1.43
Operating Lease Liability Noncurrent7.05
Total Liabilities38.93
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock0.00
Retained Earnings / Accumulated Deficit0.00
Other Equity0.00
Common Stockholder's Equity71.40
Total Stockholder's Equity71.40
Liabilities & Stockholder's Equity110.34
4 historic quarters locked

Sign in to unlock the full Protalix Biotherapeutics inc balance sheet history.

About Protalix Biotherapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-094444

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.